Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Return on Invested Capital (2019 - 2022)

Regenxbio (RGNX) has 4 years of Return on Invested Capital data on record, last reported at 0.49% in Q4 2022.

  • For Q4 2022, Return on Invested Capital fell 72.0% year-over-year to 0.49%; the TTM value through Dec 2022 reached 0.49%, down 72.0%, while the annual FY2023 figure was 0.13%, 28.0% up from the prior year.
  • Return on Invested Capital reached 0.49% in Q4 2022 per RGNX's latest filing, down from 0.15% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 13.68% in Q4 2019 and bottomed at 0.49% in Q4 2022.
  • Average Return on Invested Capital over 4 years is 0.85%, with a median of 0.07% recorded in 2021.
  • Peak YoY movement for Return on Invested Capital: tumbled -1374bps in 2020, then soared 39bps in 2022.
  • A 4-year view of Return on Invested Capital shows it stood at 13.68% in 2019, then plummeted by -100bps to 0.06% in 2020, then skyrocketed by 508bps to 0.24% in 2021, then plummeted by -306bps to 0.49% in 2022.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.49% in Q4 2022, 0.15% in Q3 2022, and 0.16% in Q2 2022.